Automated CRISPR/Cas9-based genome editing of human pluripotent stem cells using the StemCellFactory.
Nießing B, Breitkreuz Y, Elanzew A, de Toledo MAS, Vajs P, Nolden M, Erkens F, Wanek P, Au Yeung SWC, Haupt S, König N, Peitz M, Schmitt RH, Zenke M, Brüstle O.
Nießing B, et al. Among authors: schmitt rh.
Front Bioeng Biotechnol. 2024 Sep 20;12:1459273. doi: 10.3389/fbioe.2024.1459273. eCollection 2024.
Front Bioeng Biotechnol. 2024.
PMID: 39372431
Free PMC article.